top of page
Executive Spotlights

Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics

Cambridge, MA, October 2, 2023 (PRNewswire) -- Flagship Pioneering, the bioplatform innovation firm, and ProFound™ Therapeutics, an enterprise focused on expanding our understanding of the human proteome to unlock a realm of potential novel medicines, announced that Dr. John Lepore will assume the roles of CEO-Partner at Flagship Pioneering and Chief Executive Officer at ProFound, effective October 16, 2023.


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Komen


Life Science Headlines
bottom of page